Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$2.30 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Eledon Pharmaceuticals (ELDN) Cash & Current Investments (2013 - 2026)

Updated

Eledon Pharmaceuticals' Cash & Current Investments was $88.8 million in Q2 2026, down 17.5% from $107.6 million a year earlier and down 20.1% from the prior quarter.

Analysis

Eledon Pharmaceuticals (ELDN) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Eledon Pharmaceuticals came in at $133.3 million, down 4.9% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $140.18 million in FY2024 (+174.3%), $51.1 million in FY2023 (-9.4%), $56.41 million in FY2022 (-33.5%) and $84.83 million in FY2021 (-25.7%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q3 2024.
  • Compared with a year earlier, Cash & Current Investments has declined for three straight quarters, with growth averaging 51.4% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2025 (growth of 191.1%); the worst was Q1 2023 (a decline of 39.4%).
  • Per Business Quant data, ELDN's Cash & Current Investments in the three quarters before Q2 2026 was $111.1 million (Q1 2026), $133.3 million (Q4 2025) and $93.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Eledon Pharmaceuticals 258.51 Mn 169.71 Mn - 88.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88.80 Mn
Mar 31, 2026 111.10 Mn
Dec 31, 2025 133.30 Mn
Sep 30, 2025 93.40 Mn
Jun 30, 2025 107.60 Mn
Mar 31, 2025 124.90 Mn
Dec 31, 2024 140.18 Mn
Sep 30, 2024 78.20 Mn
Jun 30, 2024 83.60 Mn
Mar 31, 2024 42.90 Mn
Dec 31, 2023 51.10 Mn
Sep 30, 2023 59.60 Mn
Jun 30, 2023 71.40 Mn
Mar 31, 2023 46.50 Mn
Dec 31, 2022 56.41 Mn
Sep 30, 2022 65.89 Mn
Jun 30, 2022 70.46 Mn
Mar 31, 2022 76.68 Mn
Dec 31, 2021 84.83 Mn
Sep 30, 2021 94.04 Mn
API Access

Eledon Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ELDN&period=max&api_key=YOUR_API_KEY